These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32643505)
1. Ligustilide alleviates the insulin resistance, lipid accumulation, and pathological injury with elevated phosphorylated AMPK level in rats with diabetes mellitus. Guo S; Wang G; Yang Z J Recept Signal Transduct Res; 2021 Feb; 41(1):85-92. PubMed ID: 32643505 [TBL] [Abstract][Full Text] [Related]
2. Bilobalide Enhances AMPK Activity to Improve Liver Injury and Metabolic Disorders in STZ-Induced Diabetes in Immature Rats via Regulating HMGB1/TLR4/NF- Zhao M; Qin J; Shen W; Wu A Biomed Res Int; 2021; 2021():8835408. PubMed ID: 33959665 [TBL] [Abstract][Full Text] [Related]
3. Z-Ligustilide protects vascular endothelial cells from oxidative stress and rescues high fat diet-induced atherosclerosis by activating multiple NRF2 downstream genes. Zhu Y; Zhang Y; Huang X; Xie Y; Qu Y; Long H; Gu N; Jiang W Atherosclerosis; 2019 May; 284():110-120. PubMed ID: 30897380 [TBL] [Abstract][Full Text] [Related]
4. Z-Ligustilide Ameliorates Diabetic Rat Retinal Dysfunction Through Anti-Apoptosis and an Antioxidation Pathway. Yang B; Ma G; Liu Y Med Sci Monit; 2020 Oct; 26():e925087. PubMed ID: 33011733 [TBL] [Abstract][Full Text] [Related]
5. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity. Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956 [TBL] [Abstract][Full Text] [Related]
6. [Puerarin alleviates insulin resistance in type 2 diabetic mice by modulating fetuin B-AMPK/ACC signaling pathway in the liver]. Gao J; Liu M; Guo Z; Hu C; Feng Z; Yan J Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):839-846. PubMed ID: 34238735 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism. Xie T; So WY; Li XY; Leung PS Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570 [TBL] [Abstract][Full Text] [Related]
8. Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats. Aboulmagd YM; El-Bahy AAZ; Menze ET; Azab SS; El-Demerdash E Eur J Pharmacol; 2020 Aug; 881():173224. PubMed ID: 32454118 [TBL] [Abstract][Full Text] [Related]
9. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats. Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461 [TBL] [Abstract][Full Text] [Related]
10. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway. Yin Y; Fang Z; Wu Y; You L J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203 [TBL] [Abstract][Full Text] [Related]
11. Chitosan-stabilized selenium nanoparticles alleviate cardio-hepatic damage in type 2 diabetes mellitus model via regulation of caspase, Bax/Bcl-2, and Fas/FasL-pathway. Mohamed AA; Khater SI; Hamed Arisha A; Metwally MMM; Mostafa-Hedeab G; El-Shetry ES Gene; 2021 Feb; 768():145288. PubMed ID: 33181259 [TBL] [Abstract][Full Text] [Related]
12. Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Peng B; Zhao P; Lu YP; Chen MM; Sun H; Wu XM; Zhu L Brain Res; 2013 Jul; 1520():168-77. PubMed ID: 23688544 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy. Zhou W; Ye S Cell Biol Int; 2018 Sep; 42(10):1282-1291. PubMed ID: 29908010 [TBL] [Abstract][Full Text] [Related]
14. Effect of CAPE-pNO Li S; Huang Q; Zhang L; Qiao X; Zhang Y; Tang F; Li Z Eur J Pharmacol; 2019 Jun; 853():1-10. PubMed ID: 30885574 [TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats. Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077 [TBL] [Abstract][Full Text] [Related]
16. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway. Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256 [TBL] [Abstract][Full Text] [Related]
17. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes. Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333 [TBL] [Abstract][Full Text] [Related]
18. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine monophosphate-activated protein kinase activity and lipogenic gene expression in high-fat diet-fed obese mice. Saito T; Nishida M; Saito M; Tanabe A; Eitsuka T; Yuan SH; Ikekawa N; Nishida H Nutr Res; 2016 Oct; 36(10):1090-1097. PubMed ID: 27865350 [TBL] [Abstract][Full Text] [Related]
19. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Fu D; Cui H; Zhang Y Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]